Management of Persistent Corneal Epithelial Defects with Human Amniotic Membrane-derived Dry Matrix

OBJECTIVE: To report the outcomes of using human amniotic membrane-derived dry matrix (AMDDM) in the management of persistent corneal epithelial defects (PEDs) of various etiologies. METHODS: A cohort study of 84 patients age range 7 to 92 years with 93 PEDs were treated with AMDDM (Omnigen(®) using...

Descripción completa

Detalles Bibliográficos
Autores principales: Maqsood, Sundas, Elsawah, Kareem, Dhillon, Navpreet, Soliman, Shady, Laginaf, Masara, Lodhia, Vaishali, Lake, Damian, Hamada, Samer, Elalfy, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169046/
https://www.ncbi.nlm.nih.gov/pubmed/34093006
http://dx.doi.org/10.2147/OPTH.S299141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169046/
https://www.ncbi.nlm.nih.gov/pubmed/34093006
http://dx.doi.org/10.2147/OPTH.S299141

Ejemplares similares